Literature DB >> 20574809

MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis.

Marco Ragusa1, Alessandra Majorana, Barbara Banelli, Davide Barbagallo, Luisa Statello, Ida Casciano, Maria Rosa Guglielmino, Laura Rita Duro, Marina Scalia, Gaetano Magro, Cinzia Di Pietro, Massimo Romani, Michele Purrello.   

Abstract

MicroRNAs (MIRs) perform critical regulatory functions within cell networks, both in physiology as well as in pathology. Through the positional gene candidate approach, we have identified three MIRs (MIR152, MIR200B, and MIR338) that are located in regions frequently altered in neuroblastoma (NB) and target mRNAs encoding proteins involved in cell proliferation, neuroblast differentiation, neuroblast migration, and apoptosis. Expression analysis in NB biopsies and NB cell lines showed that these MIRs are dysregulated. We have characterized a CpG island, close to the gene encoding MIR200B and hypermethylated in NB samples, that explains its negative regulation. Expression of MIR152, MIR200B, and MIR338 is specifically modulated in NB cell lines during differentiation and apoptosis. Functional genomic experiments through enforced expression of MIR200B and knockdown of MIR152 resulted in a significant decrease of the invasion activity of SH-SY5Y cells. Reconstruction of a NB network comprising MIR152, MIR200B, and MIR338 allowed us to confirm their role in the control of NB cell stemness and apoptosis: This suggests that altered regulation of these MIRs could have a role in NB pathogenesis by interfering with the molecular mechanisms, which physiologically control differentiation and death of neuroblasts. Accordingly, they could be considered as new NB biomarkers and potential targets of antagomirs or epigenetic therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574809     DOI: 10.1007/s00109-010-0643-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  Azacitidine.

Authors:  Jean-Pierre J Issa; Hagop M Kantarjian; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

2.  Integration of biological networks and gene expression data using Cytoscape.

Authors:  Melissa S Cline; Michael Smoot; Ethan Cerami; Allan Kuchinsky; Nerius Landys; Chris Workman; Rowan Christmas; Iliana Avila-Campilo; Michael Creech; Benjamin Gross; Kristina Hanspers; Ruth Isserlin; Ryan Kelley; Sarah Killcoyne; Samad Lotia; Steven Maere; John Morris; Keiichiro Ono; Vuk Pavlovic; Alexander R Pico; Aditya Vailaya; Peng-Liang Wang; Annette Adler; Bruce R Conklin; Leroy Hood; Martin Kuiper; Chris Sander; Ilya Schmulevich; Benno Schwikowski; Guy J Warner; Trey Ideker; Gary D Bader
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

Authors:  Cameron P Bracken; Philip A Gregory; Natasha Kolesnikoff; Andrew G Bert; Jun Wang; M Frances Shannon; Gregory J Goodall
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

4.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

5.  Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.

Authors:  Barbara Banelli; Stefano Bonassi; Ida Casciano; Katia Mazzocco; Angela Di Vinci; Paola Scaruffi; Claudio Brigati; Giorgio Allemanni; Luana Borzì; Gian Paolo Tonini; Massimo Romani
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

6.  Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.

Authors:  Yongxin Chen; Raymond L Stallings
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

7.  Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells.

Authors:  Johannes H Schulte; Jutta Kirfel; Soyoung Lim; Alexander Schramm; Nicolaus Friedrichs; Hedwig E Deubzer; Olaf Witt; Angelika Eggert; Reinhard Buettner
Journal:  Cancer Lett       Date:  2008-07-11       Impact factor: 8.679

8.  Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Authors:  Jianshi Yu; Scott Becka; Peng Zhang; Xiaodong Zhang; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

Review 9.  Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution.

Authors:  Bharat B Aggarwal; Gautam Sethi; Kwang Seok Ahn; Santosh K Sandur; Manoj K Pandey; Ajaikumar B Kunnumakkara; Bokyung Sung; Haruyo Ichikawa
Journal:  Ann N Y Acad Sci       Date:  2006-12       Impact factor: 5.691

10.  The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy.

Authors:  Nadine Van Roy; Katleen De Preter; Jasmien Hoebeeck; Tom Van Maerken; Filip Pattyn; Pieter Mestdagh; Joëlle Vermeulen; Jo Vandesompele; Frank Speleman
Journal:  Genome Med       Date:  2009-07-27       Impact factor: 11.117

View more
  19 in total

1.  Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors.

Authors:  Marco Ragusa; Luisa Statello; Marco Maugeri; Alessandra Majorana; Davide Barbagallo; Loredana Salito; Mariangela Sammito; Manuela Santonocito; Rosario Angelica; Andrea Cavallaro; Marina Scalia; Rosario Caltabiano; Giuseppe Privitera; Antonio Biondi; Maria Di Vita; Alessandro Cappellani; Enrico Vasquez; Salvatore Lanzafame; Elisabetta Tendi; Salvatore Celeste; Cinzia Di Pietro; Francesco Basile; Michele Purrello
Journal:  J Mol Med (Berl)       Date:  2012-06-04       Impact factor: 4.599

2.  IGF2BP2 stabilized FBXL19-AS1 regulates the blood-tumour barrier permeability by negatively regulating ZNF765 by STAU1-mediated mRNA decay.

Authors:  Xiaobai Liu; Peiqi Wu; Rui Su; Yixue Xue; Chunqing Yang; Di Wang; Xuelei Ruan; Jian Zheng; Yang Yang; Zhen Li; Yunhui Liu
Journal:  RNA Biol       Date:  2020-07-25       Impact factor: 4.652

3.  MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.

Authors:  Andrej Besse; Jiri Sana; Radek Lakomy; Leos Kren; Pavel Fadrus; Martin Smrcka; Marketa Hermanova; Radim Jancalek; Stefan Reguli; Radim Lipina; Marek Svoboda; Pavel Slampa; Ondrej Slaby
Journal:  Tumour Biol       Date:  2015-12-21

4.  miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients.

Authors:  Bruna De Felice; Anna Annunziata; Giuseppe Fiorentino; Marco Borra; Elio Biffali; Cinzia Coppola; Roberto Cotrufo; Johannes Brettschneider; Maria Luisa Giordana; Tamas Dalmay; Guy Wheeler; Raffaella D'Alessandro
Journal:  Neurogenetics       Date:  2014-08-19       Impact factor: 2.660

5.  ATRA induces the differentiation of hepatic progenitor cells by upregulating microRNA-200a.

Authors:  Chaoqun Hu; Xiaohua Liang; Shuyu Fang; Lei Xu; Mengjia Gong; Yi Wang; Yang Bi; Siqi Hong; Yun He
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-09-12       Impact factor: 2.416

Review 6.  MicroRNA and DNA methylation alterations mediating retinoic acid induced neuroblastoma cell differentiation.

Authors:  Raymond L Stallings; Niamh H Foley; Isabella M Bray; Sudipto Das; Patrick G Buckley
Journal:  Semin Cancer Biol       Date:  2011-07-13       Impact factor: 15.707

7.  MicroRNA-338 Attenuates Cortical Neuronal Outgrowth by Modulating the Expression of Axon Guidance Genes.

Authors:  Aron Kos; Teun Klein-Gunnewiek; Julia Meinhardt; Nikkie F M Olde Loohuis; Hans van Bokhoven; Barry B Kaplan; Gerard J Martens; Sharon M Kolk; Armaz Aschrafi
Journal:  Mol Neurobiol       Date:  2016-05-14       Impact factor: 5.590

Review 8.  MicroRNAs in neuroblastoma: small-sized players with a large impact.

Authors:  Feng Zhi; Rong Wang; Qiang Wang; Lian Xue; Danni Deng; Suinuan Wang; Yilin Yang
Journal:  Neurochem Res       Date:  2014-01-30       Impact factor: 3.996

9.  miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer.

Authors:  Xuexiang Liu; Jinwan Li; Fengxian Qin; Shengming Dai
Journal:  Oncol Lett       Date:  2016-04-28       Impact factor: 2.967

10.  Genome-wide promoter methylation analysis in neuroblastoma identifies prognostic methylation biomarkers.

Authors:  Anneleen Decock; Maté Ongenaert; Jasmien Hoebeeck; Katleen De Preter; Gert Van Peer; Wim Van Criekinge; Ruth Ladenstein; Johannes H Schulte; Rosa Noguera; Raymond L Stallings; An Van Damme; Geneviève Laureys; Joëlle Vermeulen; Tom Van Maerken; Frank Speleman; Jo Vandesompele
Journal:  Genome Biol       Date:  2012-10-03       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.